Literature DB >> 1838125

Biochemical characterization of beta-hexosaminidase in different biological specimens from eleven patients with GM2-gangliosidosis B1 variant.

M G Ribeiro1, R A Pinto, M R Dos Santos, M Maia, M C Sá Miranda.   

Abstract

GM2-gangliosidosis B1 variant is thought to be a rare disorder with a wide geographical and ethnic distribution. We report the biochemical findings obtained in different specimens from a group of 11 B1 variant patients originating from the north of Portugal. The biochemical data obtained seem to indicate that only one of these patients is a genetic compound presenting a clinical and biochemical pattern similar to the majority of B1 variant patients described in the literature, but somewhat different from the profile presented by the other patients reported here, who are homozygous for the 'DN-allele'.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1838125     DOI: 10.1007/bf01799940

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  12 in total

1.  A routine method for the establishment of permanent growing lymphoblastoid cell lines.

Authors:  H Neitzel
Journal:  Hum Genet       Date:  1986-08       Impact factor: 4.132

2.  Intermediate forms of human beta-N-acetylhexosaminidase lack activity towards 4-methylumbelliferyl beta-N-acetylglucosaminide 6-sulphate.

Authors:  T Beccari; C Emiliani; R Hosseini; A Orlacchio; J L Stirling
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

3.  Electrophoretic study of hexosaminidases. Hexosaminidase C.

Authors:  L Poenaru; J C Dreyfus
Journal:  Clin Chim Acta       Date:  1973-02-12       Impact factor: 3.786

4.  Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts.

Authors:  L M Jonsson; G J Murray; S H Sorrell; A Strijland; J F Aerts; E I Ginns; J A Barranger; J M Tager; A W Schram
Journal:  Eur J Biochem       Date:  1987-04-01

5.  Mutation in GM2-gangliosidosis B1 variant.

Authors:  K Ohno; K Suzuki
Journal:  J Neurochem       Date:  1988-01       Impact factor: 5.372

6.  GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients.

Authors:  A Tanaka; K Ohno; K Sandhoff; I Maire; E H Kolodny; A Brown; K Suzuki
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

7.  Sodium taurocholate effect on beta-glucosidase activity: a new approach for identification of Gaucher disease using the synthetic substrate and leucocytes.

Authors:  J Magalhães; M C Sá Miranda; R Pinto; M Lemos; L Poenaru
Journal:  Clin Chim Acta       Date:  1984-08-31       Impact factor: 3.786

8.  Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A.

Authors:  H J Kytzia; K Sandhoff
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

9.  B1 variant of GM2 gangliosidosis in a 12-year-old patient.

Authors:  H H Goebel; G Stolte; B Kustermann-Kuhn; K Harzer
Journal:  Pediatr Res       Date:  1989-01       Impact factor: 3.756

10.  Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity.

Authors:  H J Kytzia; U Hinrichs; I Maire; K Suzuki; K Sandhoff
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  2 in total

1.  Clinical, enzymatic, and molecular characterisation of a Portuguese family with a chronic form of GM2-gangliosidosis B1 variant.

Authors:  M G Ribeiro; T Sonin; R A Pinto; A Fontes; H Ribeiro; E Pinto; M M Palmeira; M C Sá Miranda
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

2.  Identification of GM2-gangliosidosis B1 variant carriers.

Authors:  M G Ribeiro; R Pinto; P Oliveira; M C Sá Miranda
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.